A Phase I Study to Evaluate the Effects of Multiple-dose D-1553 on Pharmacokinetics of Single-dose Midazolam, Caffeine, Rosuvastatin, Furosemide and Digoxin, and to Evaluate the Effects of Multiple-dose Itraconazole and Omeprazole on Pharmacokinetics of Single-dose D-1553 in Healthy Male Subjects
Latest Information Update: 19 Nov 2024
At a glance
- Drugs Garsorasib (Primary)
- Indications Colorectal cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors InventisBio
Most Recent Events
- 15 Oct 2024 Status changed from active, no longer recruiting to completed.
- 31 Oct 2023 New trial record